Alnylam Pharmaceuticals, Inc.

Beacon Pointe Advisors, LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

790

Value ($000)

314

Weight

0.0%

2021 Q3 - 2025 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	314	0.0%	790	12/31/2025
2025 Q3	11/14/2025	435	0.0%	954	9/30/2025
2025 Q2	8/13/2025	338	0.0%	1,036	6/30/2025
2025 Q1	5/13/2025	234	0.0%	867	3/31/2025
2024 Q4	2/14/2025	220	0.0%	935	12/31/2024
2024 Q3	11/14/2024	378	0.0%	1,375	9/30/2024
2024 Q2	8/12/2024	367	0.0%	1,512	6/30/2024
2024 Q1	5/14/2024	245	0.0%	1,636	3/31/2024
2023 Q4	2/8/2024	313	0.0%	1,636	12/31/2023
2023 Q3	11/14/2023	299	0.0%	1,691	9/30/2023
2023 Q2	8/14/2023	300	0.0%	1,580	6/30/2023
2023 Q1	5/12/2023	342	0.0%	1,706	3/31/2023
2022 Q4	2/14/2023	425	0.0%	1,790	12/31/2022
2022 Q3	11/9/2022	351	0.0%	1,757	9/30/2022
2022 Q2	8/11/2022	235	0.0%	1,601	6/30/2022
2022 Q1	5/17/2022	284	0.0%	1,740	3/31/2022
2021 Q4	2/14/2022	228	0.0%	1,345	12/31/2021
2021 Q3	11/15/2021	293	0.0%	1,550	9/30/2021